All posts by imreal

The Effects of the Affordable Care Act on Seasonal Agricultural Workers


News Image

The probability a seasonal agricultural worker has health insurance rises by 11% if the worker is Medicaid-eligible and by 3% if subsidy-eligible. The Affordable Care Act included Medicaid expansion, a health insurance premium subsidy, and a tax penalty for not having insurance coverage.

In the new article released in the open access Journal of the Agricultural & Applied Economics Association “The Effects of the Affordable Care Act on Seasonal Agricultural Workers” Kwabena Donkor from the Stanford Graduate School of Business, and Jeffrey Perloff from the University of California, Berkeley examine how the three Affordable Care Act policies affected farmworkers’ health insurance coverage and healthcare utilization.

Donker says, “this study investigates the effects of more ACA policies—including federal premium subsidies, tax penalties, and protections for people with pre-existing medical conditions—than previous studies. It is the first to examine how the ACA’s effects depend on pre-existing medical conditions. It is the first to address whether individual farmworkers were eligible for Medicaid or to receive a subsidy based on their incomes and family size.”

If you are interested in setting up an interview, please contact Allison Ware in the AAEA Business Office.

ABOUT AAEA: Established in 1910, the Agricultural & Applied Economics Association (AAEA) is the leading professional association for agricultural and applied economists, with 2,500 members in more than 60 countries. Members of the AAEA work in academic or government institutions as well as in industry and not-for-profit organizations, and engage in a variety of research, teaching, and outreach activities in the areas of agriculture, the environment, food, health, and international development. The AAEA publishes three journals, the Journal of the Agricultural and Applied Economics Association (an open access journal), the American Journal of Agricultural Economics and Applied Economic Perspectives & Policy, as well as the online magazine Choices and the online open access publication series Applied Economics Teaching Resources. To learn more, visit http://www.aaea.org.

Share article on social media or email:

GHX Opens Nominations for 2022 GHXcellence Awards


Global Healthcare Exchange (GHX) today announced it has opened its call for nominations for the 2022 GHXcellence Awards. The 2022 GHXcellence Award winners will be announced at the annual GHX Summit – taking place in Chicago, May 9-12, 2023.

Each year, the GHXcellence Awards program recognizes leaders and visionaries going above and beyond to support the patients and communities they serve through innovative advancements in the business of healthcare. Nominations can be submitted by or on behalf of any healthcare provider or supplier organization or individual. A nominee is not required to be a GHX customer to be eligible.

Winners will be chosen by a selection committee including GHX executives and leading healthcare influencers including Eugene Schneller, Ph.D., Professor at the WP Carey School of Business, Arizona State University and Co-Founder of Healthcare Supply Chain eXcellence; Dennis Black, UDI Program Director, Global Regulatory Affairs, Becton, Dickinson and Company; Mark Van Sumeren, Managing Director, Health Industry Advisor, LLC; and Jack Koczela, Director of Services, Supply Chain, Froedtert Health.

“Each year, the healthcare industry produces outstanding examples of inspirational leadership and innovation – and 2022 was no exception,” said Tina Vantaka Murphy, current division president, Value Based Care, and incoming president and CEO of GHX. “We continue to see displays of profound resilience and triumphant successes in the face of challenging circumstances and we look forward to recognizing the accomplishments of this great community.”

The 2022 GHXcellence Awards include:

Organizational Awards:

Collaboration: Recognizes organizations that valued and leveraged relationships with other organizations to support the needs of patients and communities by establishing coalitions, collaborations and partnerships within and/or outside their organization.

Innovation: Recognizes organizations that demonstrated unique ways of solving complex problems and exhibited the courage to drive new solutions forward.​

Community Impact: Recognizes organizations that improved the health of the community in which they reside by forming coalitions with other business leaders to solve community health problems, support local businesses and provide motivating pathways to mentor and educate local talent.​

Commitment to Safety and Security​: Recognizes organizations that have demonstrated a commitment to the safety and security of their patients, visitors and employees.​

Achieving Financial Agility in Invoicing and Payments: Recognizes organizations that are utilizing the savings from increasing payment efficiencies and automation to help lower the cost of doing business and deliver better patient value.​

Elevating the Clinically Integrated Supply Chain: Recognizes organizations that are using or generating evidence to redesign care to improve outcomes relative to costs​ and elevating the maturity of health systems in becoming clinically integrated in the supply chain​.

Individual Awards:

Key Contributor: Individuals who were key contributors to the above-listed awards may be recognized for their vision and drive that made it possible for the organization to achieve success and the GHXcellence Award.

Healthcare Hero: These individuals are innovators, risk-takers and futurists. They are making great strides in how things are done in healthcare, teaching us all a better way and showing measurable improvements from their efforts.

Supply Chain Leadership: This award recognizes individuals in supply chain leadership roles, from provider and/or supplier organizations, who are transforming the business of healthcare and supply chain through the innovative use of technology and industry collaboration.

One or more winners may be recognized in each award category, based on nominations received and as determined by the selection committee. More information on nominations, including award criteria and updates can be found at http://www.ghx.com/awards/ghxcellence. Nominations will be accepted through January 31, 2023.

About GHX

Building on decades of collaboration among providers, manufacturers, distributors and other industry stakeholders, Global Healthcare Exchange, LLC (GHX) is leading the charge in helping organizations run the new business of healthcare. By automating key business processes and translating evidence-based analytics and data into meaningful action, GHX is helping the healthcare ecosystem to move faster, operate more intelligently and achieve greater outcomes. With the support of GHX, healthcare organizations have removed billions of dollars of wasteful healthcare spend. For more information on GHX’s suite of cloud-based supply chain solutions, visit http://www.ghx.com and The Healthcare Hub.

Share article on social media or email:

Pet Parents are Invited to Enter “Happy Howlidays PetMeds® Giveaway”


“Cats and dogs may not understand why they get extra treats or toys around the holidays, though they surely appreciate them,” says Larissa Schenck, director of marketing at PetMeds®. “But what truly makes the holidays special for pets is making memories and being treated as a part of the family.”

According to the American Pet Products Association (APPA), it’s becoming increasingly common for pet parents to celebrate the holidays with their pets, with 35% of cat owners and 45% of dog owners reportedly planning to get their pets gifts this year.

Pet parents are also finding new ways to include pets in longstanding holiday traditions. For example, many are making Advent calendars full of dog treats instead of chocolates, wrapping up a new toy for each night of Hanukkah, or stuffing Christmas stockings full of favorite treats.

New holiday traditions, too, are becoming the norm for families with pets. Pet parents can take their dog for an evening walk to take in the neighborhood light displays or get their cat matching pajamas for the annual family photo.

The holidays are also a time for pets to give back by signing a holiday card to send to their favorite vet or groomer with a pawprint, or even “sponsoring” a donation of money or supplies to their alma mater animal shelter.

“Cats and dogs may not understand why they get extra treats or toys around the holidays, though they surely appreciate them,” says Larissa Schenck, director of marketing at PetMeds®. “But what truly makes the holidays special for pets is making memories and being treated as a part of the family.”

Pet parents are invited to celebrate the holiday season by entering the “Happy Howlidays” giveaway for a chance to win a cat or dog prize pack from PetMeds®. The cat prize pack will include Inaba Churu Cat Treat/Topper Chicken Variety-10 pack, Catnip Garden 4 oz. bag, and a Natural Pet Woolly Mouse Cat toy. For dogs, the prize pack will include a set of 2 Fundog Christmas Bandanas, Christmas Bark Turkey & Carrots Dog Treats 5 oz., and a Gingerbread Crinkle Dog Toy. Two grand prize winners will receive a Paw Print Frame.

The Happy Howlidays with PetMeds® giveaway runs from December 1, 2022, through December 30, 2022. Everyone who enters from 12:01 AM Eastern Time (“ET”) December 1, 2022, to December 30, 2022, at 11:59 PM ET is eligible to win a cat or dog prize pack. One cat and one dog winner will be chosen each week for a total of ten (10) winners.

ABOUT PETMEDS

Founded in 1996, Petmeds.com is Your Trusted Pet Health Expert, providing fast, easy, and helpful service to over 10 million customers across North America. PetMeds® delivers prescription and non-prescription medications and pet supplies for less, direct to the consumer through its PetMeds® toll-free number, on the Internet through its website Petmeds.com, or with the PetMeds® free mobile app available for Apple and Android devices.

Share article on social media or email:

Catalent Completes Expansion of Clinical Supply Facility in Shanghai, China


Catalent's clinical supply facility in the Waigaoqiao Free Trade Zone in Shanghai, China

Catalent’s clinical supply facility in the Waigaoqiao Free Trade Zone in Shanghai, China

China is the fastest growing clinical trials market in the Asia-Pacific region, and… these additional capabilities increase the site’s ability to support clinical trials for advanced therapeutics, which often require specialized storage and handling capabilities.

Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has completed the expansion of its clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.

The project has seen the site increase by approximately 30,000 square feet (approximately 2,800 square meters), which has allowed the installation of additional refrigerated (between 2 and 8 degrees Celsius) and deep-frozen (between minus 70 and minus 90 degrees Celsius) storage, and secondary packaging capabilities to be expanded. The completion will be marked by two customer events, on Dec. 1 and Dec. 6, where members of Catalent’s senior management team will be showcasing the facilities at the site and hosting workshops on clinical supply management and new GMP policies.

“China is the fastest growing clinical trials market in the Asia-Pacific region, and Catalent continues to invest and expand its facilities and services to offer reliable, flexible, and integrated support to customers,” said Tracey Clare, General Manager, APAC Operations, Catalent. “These additional capabilities increase the site’s ability to support clinical trials for advanced therapeutics, which often require specialized storage and handling capabilities.”

The Waigaoqiao facility is one of two clinical supply facilities that Catalent operates in Shanghai, the other being in Tangzhen, outside the FTZ. Together, they provide sponsors with optimized supply solutions for studies being undertaken in China, and through Catalent’s extensive network, the Asia-Pacific region and globally. These include clinical supply management, comparator sourcing, FastChain® demand-led supply, primary and secondary packaging, storage, and global distribution, as well as clinical returns and destruction.

About Catalent

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.

Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 18,000 includes more than 3,000 scientists and technicians.

Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Alucio™ Releases Updated Presentation Builder Feature for its Beacon Platform


News Image

“Beacon’s integrated presentation builder is a key platform feature that aligns with an important and growing trend toward personalization in the market.” said Lauren Keyes, Director of Product Management.

Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced updates to its unique presentation builder feature within its Beacon scientific exchange platform. These enhancements provide users with new content assembly options while ensuring pharma regulatory compliance. Beacon is a modern content activation and HCP engagement platform built specifically for Medical Science Liaisons (MSLs), Medical Affairs professionals, and Market Access teams.

Beacon’s presentation builder stands out by offering the most advanced and user-friendly content assembly capabilities in the marketplace today. It helps Medical Science Liaisons, Market Access Account Directors, and Content Administrators curate and tailor presentations to meet the specific information needs of their audiences in a dynamic way. This feature is conveniently offered within the desktop, laptop, and tablet instances of Beacon, and in both online and offline modes.

These latest updates make selecting desired slides during the content assembly process more streamlined and allow for multiple slide grouping options within a file. They also make the sorting and repositioning of material, including any required content, faster and more efficient.

Moreover, of particular note, users now have the flexibility to create custom presentations using diverse content assets and formats that go beyond traditional PowerPoint slides and can include PDF pages, website pages, HTML5 applications, videos, and animations. These changes enable MSLs and Account Directors to be more effective storytellers and lead to more impactful HCP engagements.

Additional updates to Beacon’s presentation builder include more detailed reporting on content usage, enhanced collaboration amongst internal teams in the development of custom presentations, and smarter document sharing with external stakeholders. These enhancements further elevate the ability of users to provide even more targeted engagement experiences.

“Beacon’s integrated presentation builder is a key platform feature that aligns with an important and growing trend toward personalization in the market. These new, enhanced presentation builder features were fully informed by our active user community,” said Lauren Keyes, Director of Product Management. “We are very excited about how this capability within Beacon continues to evolve to offer even more value for our customers!”

To learn more about Beacon and to schedule a product demonstration, please contact the company at sales@alucio.io.

About Alucio:

Alucio is dedicated to the development of innovative software applications specifically for the life sciences industry. Alucio’s flagship product, Beacon, is a modern, cloud-based scientific exchange platform that enhances scientific dialogue and engagement between life science companies and healthcare professionals. For more information, please visit the company’s website at http://www.alucio.io or contact Lisa Amin at lamin@alucio.io (925) 788-3533.

Share article on social media or email:

Dental Care Alliance Expands Texas Footprint with Addition of Alsbury Dental and Lifeway Dental


“We are excited to be working with DCA,” said Dr. Foust. “Their commitment to patient care is why we chose them, and they have been a pleasure to work with.”

Dental Care Alliance (DCA) is proud to announce the expansion of its footprint in the Dallas Fort Worth area with the addition of Alsbury Dental and Lifeway Dental. Alsbury Dental and Lifeway Dental is a four-doctor, two-location general dentistry practice with locations in Burleson and Alvarado, Texas, south of Fort Worth.

The practice, led by Dr. Blake Foust and four associates, is passionate about their shared philosophy to make patients feel comfortable and at ease with each visit to the dentist. By staying current in dental technologies and advancements, the entire staff is well-educated, comprehensively trained, and empowered to provide friendly, personalized experiences ensuring every patient feels that they are in good hands.

Alsbury Dental, located in Burleson, TX, is a full-service family practice offering a range of services including teeth whitening, sedation dentistry, SureSmile® clear aligners, and more.

Lifeway Dental, located in Alvardo, TX, offers a wide array of services including general family dentistry, implant dentistry, cosmetic dentistry, bridges, crowns, dental emergencies, dentures, fillings, root canals, teeth whitening and more.

The hundreds of impressive Google reviews and awards including Local Life’s “Best Dentist in Burleson, Texas” are testament to the thoughtful and exceptional care that is the hallmark of each location.

Dr. Blake Foust earned his dental degree and implantology certificate at Loma Linda University after completing an undergraduate degree in chemistry from Southern Adventist University. He started Alsbury Dental in 1989 and in addition to general dentistry, is experienced in providing patients with dental implants. Dr. Foust holds a fellowship in the American Academy of Implant Dentistry and the American Board of Implant Dentistry, where he is also a diplomate. Dr. Foust is joined by four associates:


  • Dr. Robert Davis earned a bachelor’s degree in chemistry and a minor in math from Baylor University, before entering Baylor College of Dentistry to earn his doctorate in dental medicine. Dr. Davis achieved honor roll status and was awarded 4th Academic Honors at Baylor College of Dentistry. He completed an AEGD Residency and then became part of our practice in 2016.
  • Dr. Megan Belken studied at Baylor University, earning her undergraduate degree with a major in biology and minor in chemistry. She achieved her doctorate in dental science (DDS) at the University of Texas Health Science Center Dental Branch. She went on to complete a General Practice Residency with the University of Michigan where she focused on hospital dentistry; heavy in emergencies, special needs, and dental care for those undergoing treatment for cancer.
  • Dr. Huyen Nguyen considers herself a Texan girl by heart, although she was born in Louisiana. She has lived in Dallas all her life, attending kindergarten through high school where she graduated as Valedictorian of her class. After high school, she continued her education at The University of Texas at Austin where she earned her bachelor’s degree in biology and Minor in Business. She then pursued her Doctorate degree at Midwestern University College of Dental Medicine in Chicago, Illinois.
  • Dr. Devarshee Patel is a proud Texas resident and grew up in Coppell, TX. She graduated from Coppell High School then went to pursue her undergraduate and a graduate degree in Neuroscience from the University of Texas at Dallas. She earned her doctorate degree from Texas A&M Baylor College of Dentistry.

“We are excited to be working with DCA,” said Dr. Foust. “Their commitment to patient care is why we chose them, and they have been a pleasure to work with.”

This affiliation continues the rapid growth and momentum for the organization and brings DCA’s footprint in Texas to 34 allied practices, and DCA’s total footprint to over 390 allied practices across the US. “Dr. Foust built his practices with an unwavering focus on providing a premier patient experience, something that remains a keystone of each office’s culture,” said Mike Calder, Vice President, Business Development for DCA. “We are proud to enhance our network with Dr. Foust, the associate doctors, and his team; and we are looking forward to supporting them in their continued success.”

With the growing footprint in the DFW area consisting of eight practice locations that collectively cover all dental services, DCA is strategically building market density to serve the lifetime needs of patients in these communities.

Dental Care Alliance’s mission is to advance the practice of dentistry by partnering with and supporting dental professionals to create a lifetime of healthy smiles. DCA currently supports over 390 allied practices with more than 775 dentists across 22 states. DCA’s allied practices represent all dental specialties and treat patients under more than 140 brand names.

#####

Share article on social media or email:

T3P – A Versatile Peptide Coupling and Water Removal Reagent, Offering Several Process Advantages, Upcoming Webinar Hosted by Xtalks


The reagent may readily be used for various other functional group transformation reactions including nitrile formation from carboxamides, alcohol oxidation (Swern-type oxidation), ester formation, Lossen rearrangement, Beckmann rearrangement and heterocycle formation.

T3P or propanephosphonic acid anhydride, is an exceptional green reagent for use in condensation reactions and has attracted the attention of almost all innovative pharmaceutical companies worldwide during the past decade. Many applications for T3P use are in amidations and peptide coupling reactions — both LPPS (liquid-phase peptide synthesis) and SPPS (solid-phase peptide synthesis). However, the reagent may readily be used for various other functional group transformation reactions including nitrile formation from carboxamides, alcohol oxidation (Swern-type oxidation), ester formation, Lossen rearrangement, Beckmann rearrangement and heterocycle formation.

Register for this webinar to learn about a versatile peptide coupling & water removal reagent that offers several process advantages.

Join Dr. Peter Talbiersky, Fine Chemicals Business Development Manager, Curia Global, Inc., for the live webinar on Friday, December 16, 2022, at 9am EST (3pm CET/EU-Central).

For more information, or to register for this event, visit T3P – A Versatile Peptide Coupling and Water Removal Reagent, Offering Several Process Advantages.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Getting Neuroimaging Right — How to Succeed in Neurodegenerative Clinical Trials, Upcoming Webinar Hosted by Xtalks


In addition to clinical operations experts, attendees will hear a site’s perspective about the key requirements to obtain high-quality data efficiently and quickly.

An undisputed fact is that clinical trial delays are very costly. Any strategies that accelerate start-up are key to a study’s success in achieving timelines and expected budget. However, these drivers should not challenge the ultimate key objective of obtaining high-quality data without over-burdening the sites or the participants. In this webinar, the featured speakers will provide insights on how to address common challenges in neuroimaging studies.

This webinar includes: An overview of key considerations that impact start-up cycle times in neuroimaging clinical studies with strategies and tactics to address them; How to adopt a centralised approach to reduce cycle times in qualifying sites anywhere in the world; And how to reduce the burden to sites and patients.

In addition to clinical operations experts, attendees will hear a site’s perspective about the key requirements to obtain high-quality data efficiently and quickly.

Register today to learn more about getting neuroimaging right and succeeding in neurodegenerative clinical trials.

Join Vicky Eyre, Director, Clinical Operations, Re:Cognition Health; Romina Oxborough, PhD, Senior Vice-President Operations, IXICO; and Nicoletta Vitale, Senior Project Start-Up Manager, IXICO, for the live webinar on Tuesday, December 13, 2022, at 1pm EST (6pm GMT/UK).

For more information, or to register for this event, visit Getting Neuroimaging Right — How to Succeed in Neurodegenerative Clinical Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Bringing the Clinical Trial to the Patient in Preclinical Alzheimer’s Disease, Upcoming Webinar Hosted by Xtalks


Clinical trial teams now need testing solutions that are effective and equivalent when deployed outside of the clinical site.

With the first demonstration that anti-amyloid therapies can slow amyloid accumulation and reduce clinical disease progression in symptomatic Alzheimer’s disease, there is increasing focus on the extent to which disease modifying therapies, applied very early in AD, may delay symptom onset itself.

With focus turning to clinical trials in the preclinical stage of Alzheimer’s disease, clinical trial design is faced with new challenges and new opportunities. The requirement for identifying abnormal Alzheimer’s disease biology in cognitively unimpaired adults is being made easier with the industrialization of blood-based biomarkers for amyloid and tau. In the same vein, engaging, screening, recruiting and even assessing clinical status in cognitively unimpaired adults is facilitated through use of remote clinical assessment.

Clinical trial teams now need testing solutions that are effective and equivalent when deployed outside of the clinical site. Utilizing remote testing allows participants to be assessed from the comfort of their home, typically reducing the number of site visits, and supporting faster and more diverse recruitment which allows studies to be extended to include samples from underrepresented populations.

Cogstate technologies have been used in remote contexts in clinical trials and research for decades. This experience provides the basis for their current application in Phase III registration of trials of disease-modifying therapies in preclinical Alzheimer’s disease.

This webinar will consider the types of remote cognitive assessments that can be applied in clinical trials, aspects of trial design to which they apply and the methodological issues that require consideration when cognitive assessments are conducted remotely. The featured speakers conclude with consideration for the potential opportunities afforded by use of remote cognitive assessment in preclinical Alzheimer’s disease.

Join experts from Cogstate, Paul Maruff, PhD, Chief Innovation Officer; and Chris Edgar, PhD, Chief Science Officer, for the live webinar on Thursday, December 15, 2022, at 1pm EST (10am PST).

For more information, or to register for this event, visit Bringing the Clinical Trial to the Patient in Preclinical Alzheimer’s Disease.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

NGS Solutions for FFPE Materials — Maximizing Immuno-Oncology Insights with Challenging Clinical Samples, Upcoming Webinar Hosted by Xtalks


The physical and chemical modifications following formalin fixation can pose difficulties — such as DNA degradation, cross-linking and fragmentation — for NGS processes.

Formalin-fixed biological specimens are an invaluable resource for the extraction of DNA, RNA and protein. By providing information on single-gene mutations through next-generation sequencing (NGS) processes, FFPE (Formalin-Fixed Paraffin-Embedded) samples enable precision medicine and cancer genetics studies. In addition, FFPE tissues are more readily available and easier to handle in clinical practice than fresh frozen tissues. However, the physical and chemical modifications following formalin fixation can pose difficulties — such as DNA degradation, cross-linking and fragmentation — for NGS processes.

In this webinar, the featured speaker shares insights into FFPE fixation conditions, quality metrics that are most predictive of success, and how to leverage assay design when working with these precious specimens. Highlights of the Personalis clinical laboratory experience in providing robust genomic solutions for clinical research and diagnostic applications from both limited and challenging studies will be presented.

Register for this webinar to gain insights into maximizing immuno-oncology insights for challenging clinical samples with NGS solutions.

Join Erin N. Newburn, MS, PhD, Director, Field Applications Scientist, Personalis, Inc., for the live webinar on Thursday, December 15, 2022, at 12pm EST (9am PST).

For more information, or to register for this event, visit NGS Solutions for FFPE Materials — Maximizing Immuno-Oncology Insights with Challenging Clinical Samples.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email: